Login / Signup

Three-year update outcomes of the first chimeric antigen receptor-T therapy for children and young adults with relapsed/refractory acute lymphoblastic leukemia.

Hideki Nakayama
Published in: Translational pediatrics (2024)
Keyphrases
  • acute lymphoblastic leukemia
  • young adults
  • allogeneic hematopoietic stem cell transplantation
  • childhood cancer
  • type diabetes
  • diffuse large b cell lymphoma
  • multiple myeloma
  • adipose tissue
  • insulin resistance